Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,540 | 1 | 84.1% |
| Food and Beverage | $270.71 | 5 | 14.8% |
| Education | $20.61 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,695 | 4 | $0 (2019) |
| Tempus AI, Inc | $73.36 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $33.63 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $17.14 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.99 | 2 | Tempus AI, Inc ($73.36) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $1,695 | 4 | Celgene Corporation ($1,695) |
| 2017 | $17.14 | 1 | E.R. Squibb & Sons, L.L.C. ($17.14) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $73.36 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 07/23/2019 | Celgene Corporation | Revlimid (Drug) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Hematology / Oncology | ||||||
| 07/19/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $120.58 | General |
| Category: Hematology / Oncology | ||||||
| 07/19/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Hematology / Oncology | ||||||
| 05/29/2019 | Celgene Corporation | Abraxane (Drug) | Education | In-kind items and services | $8.69 | General |
| Category: Oncology | ||||||
| 08/10/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 190 | 409 | $140,716 | $42,551 |
| 2022 | 5 | 158 | 346 | $102,564 | $37,970 |
| 2021 | 4 | 158 | 252 | $61,956 | $22,958 |
| 2020 | 4 | 124 | 203 | $42,588 | $13,324 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 254 | $95,155 | $29,845 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 109 | $28,909 | $8,008 | 27.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $13,105 | $3,665 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $3,547 | $1,032 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 215 | $66,566 | $25,997 | 39.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $13,958 | $4,652 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 59 | $12,979 | $4,392 | 33.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 21 | $6,074 | $1,837 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $2,987 | $1,092 | 36.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 91 | $27,518 | $11,201 | 40.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 88 | $18,841 | $6,617 | 35.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,801 | $2,724 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 56 | $7,795 | $2,417 | 31.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 93 | $22,843 | $7,263 | 31.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 72 | $12,953 | $3,649 | 28.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 21 | $4,738 | $1,885 | 39.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $2,055 | $527.03 | 25.6% |
About Dr. Jane Borkowski, MD
Dr. Jane Borkowski, MD is a Hematology & Oncology healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932177847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Borkowski, MD has received a total of $1,831 in payments from pharmaceutical and medical device companies, with $106.99 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,540).
As a Medicare-enrolled provider, Borkowski has provided services to 630 Medicare beneficiaries, totaling 1,210 services with total Medicare billing of $116,803. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Kirkland, WA
- Active Since 03/08/2006
- Last Updated 09/02/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1932177847
Products in Payments
- Revlimid (Drug) $1,687
- LYNPARZA (Drug) $33.63
- OPDIVO (Biological) $17.14
- Abraxane (Drug) $8.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Kirkland
Dr. Prakash Varadarajan, M.d, M.D
Hematology & Oncology — Payments: $706.68
Erin-Siobhain Currin, M.d, M.D
Hematology & Oncology — Payments: $90.41
Carol Vanhaelst, Md, MD
Hematology & Oncology — Payments: $79.13
Timothy Carlos, Md, MD
Hematology & Oncology — Payments: $23.93
Vikram Raghunathan, Md, MD
Hematology & Oncology